SCHEMBL5667

SCHEMBL5667

CCOC[C@]1(O)CC[C@@]2(CCN(c3ccc(CC)cc3)C2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 13/20 0.37
CYP2C9 P11712 6/20 0.37
CYP1A2 P05177 6/20 0.37
USP2 O75604 6/20 0.37
ALDH1A1 P00352 5/20 0.37
HSD17B10 Q99714 5/20 0.37
HIF1A Q16665 3/20 0.37
ALOX15 P16050 2/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 8/20 0.36
TSHR P16473 3/20 0.36
S1PR1 P21453 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP2D6 P10635 1/20 0.35
MEN1 O00255 2/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5834 0.90 S1PR1 (0.37) CYP3A4CYP2C9CYP1A2USP2ALDH1A1
SCHEMBL5655 0.89 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2USP2ALDH1A1
SCHEMBL5843 0.84 ITGB3 (0.37) CYP3A4CYP2C9CYP1A2USP2ALDH1A1
SCHEMBL5680 0.83 CYP3A4 (0.43) CYP3A4CYP2C9CYP1A2USP2ALDH1A1
SCHEMBL5474 0.75 ITGB3 (0.36) CYP3A4CYP2C9CYP1A2USP2ALDH1A1
SCHEMBL9969 0.73 LIPE (0.57) S1PR1ITGB3ITGA2B
SCHEMBL12702451 0.73 LIPE (0.57) S1PR1ITGB3ITGA2B
SCHEMBL9968 0.73 LIPE (0.57) S1PR1ITGB3ITGA2B
SCHEMBL13849672 0.73 KDM4E (0.42) CYP3A4CYP2C9CYP1A2USP2ALDH1A1
SCHEMBL5611 0.72 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed